Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shen Lu

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Biorxiv : the Preprint Server for Biology|September 30, 2020
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 10, 2017
Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian WomenNeil M Iyengar, I-Chun Chen, Xi K Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2015
Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapyYen-Shen Lu, Tom Wei-Wu Chen, Ching-Hung Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2009
O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancersPei-Fang Wu, Kuan-Ting Kuo, Lu-Ting Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
DESTINY-Breast08: a phase 1b study of trastuzumab deruxtecan in combination with other anticancer therapies in patients with HER2-low metastatic breast cancerKomal Jhaveri, Sherene Loi, Erika Hamilton, et al.
Breast Cancer (Tokyo, Japan)|June 17, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 studyToshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, et al.
Journal of the National Cancer Institute|May 17, 2019
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US PopulationChing-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, et al.
Scientific Reports|February 16, 2016
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerI-Chun Chen, Yuan-Ching Chang, Yen-Shen Lu, et al.
Scientific Reports|December 17, 2015
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 AssaysChing-Hung Lin, I-Chiun Chen, Chiun-Sheng Huang, et al.
JCO Precision Oncology|September 10, 2021
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and RibociclibAditya Bardia, Fei Su, Nadia Solovieff, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Biorxiv : the Preprint Server for Biology|September 30, 2020
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 10, 2017
Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian WomenNeil M Iyengar, I-Chun Chen, Xi K Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2015
Bevacizumab preconditioning followed by Etoposide and Cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapyYen-Shen Lu, Tom Wei-Wu Chen, Ching-Hung Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 11, 2009
O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancersPei-Fang Wu, Kuan-Ting Kuo, Lu-Ting Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
DESTINY-Breast08: a phase 1b study of trastuzumab deruxtecan in combination with other anticancer therapies in patients with HER2-low metastatic breast cancerKomal Jhaveri, Sherene Loi, Erika Hamilton, et al.
Breast Cancer (Tokyo, Japan)|June 17, 2024
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 studyToshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, et al.
Journal of the National Cancer Institute|May 17, 2019
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US PopulationChing-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, et al.
Scientific Reports|February 16, 2016
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerI-Chun Chen, Yuan-Ching Chang, Yen-Shen Lu, et al.
Scientific Reports|December 17, 2015
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 AssaysChing-Hung Lin, I-Chiun Chen, Chiun-Sheng Huang, et al.
JCO Precision Oncology|September 10, 2021
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and RibociclibAditya Bardia, Fei Su, Nadia Solovieff, et al.
Pageof 24